Having brought a canine cancer treatment to market, Qbiotic's focus has returned to treating two-legged cancers including melanoma and other difficult-to-treat cancers
Four years after it was forced to overhaul its risk management, ASX again is in the midst of a comprehensive reworking of its risk management framework.